Product Commercialization Comes Into Focus at Emerging Leaders Workshop at 2011 BIO International Convention

Interactive workshop to offer insights into commercialization of new products, regulatory affairs, market access and clinical development for mid-level emerging leaders in marketing and new product commercialization, market access and clinical development

WASHINGTON--(BUSINESS WIRE)-- Enhanced understanding of commercialization for new products is critical in today’s global markets. To advance the dialogue in this area, the Biotechnology Industry Organization (BIO) will feature a one and one-half day workshop at the 2011 BIO International Convention. The Convention will take place June 27-30, 2011, in Washington, D.C. at the Walter E. Washington Convention Center, and is expected to attract more than 15,000 industry leaders from around the world.

“Dealing with shrinking budgets, aggressive competition and new regulatory pressure efficiently are central to hitting the mark in new product commercialization,” said Jim Greenwood, president and CEO of BIO. “We are pleased to partner with Campbell Alliance and Johns Hopkins on this interactive workshop featuring emerging leaders. The workshop is part of BIO’s ongoing mission to support innovative product development.”

The Emerging Leaders Workshop, co-hosted with management consulting firm Campbell Alliance and Johns Hopkins, will address an array of issues and insights for commercial development of new pharmaceutical and biotechnology products to address the needs of emerging leaders working cross-functionally to commercialize new products or in-license Phase II and Phase III assets.

Featured speakers will include keynote speakers Joshua Boger, PhD, founder and CEO (Retired) of Vertex Pharmaceuticals Incorporated and Kathleen Weldon Tregoning, vice president, government strategy, Biogen Idec. In addition, Natalie Derzko, counsel, Covington & Burling, and lecturer, Johns Hopkins University will provide remarks.

Interactive workshop objectives:

  • Provide strategic perspectives around key aspects of commercial planning
  • Outline current best practices for managing cross-functional new product commercialization
  • Compete in an interactive commercial simulation exercise designed to enhance commercial decision-making
  • Build skills to support collaboration, in-depth analysis, and strategic thinking

The Emerging Leaders Workshop will be held Monday, June 27 from 8:15 a.m. to 5:15 p.m. and Tuesday, June 28 from 8:45 a.m. to 12:30 p.m. The event is co-hosted by Campbell Alliance with support from The Johns Hopkins University. FierceBiotech is the prime media partner for the Emerging Leaders Workshop.

The BIO International Convention is the largest global event for the biotechnology industry, offering networking and partnering opportunities with policymakers, scientists, CEOs and newsmakers, and hundreds of sessions covering biotech trends, policy issues and technological innovations. The Convention also features the BIO Business Forum, a unique platform for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to gather and discuss strategic opportunities. For registration, conference agenda and exhibitor information, visit 2011 BIO International Convention.

Note to Editors: Members of the media can register at http://convention.bio.org/media.

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.

For more information:
Visit http://www.bio.org
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Pricing and Market Access, Medical Affairs, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Somerset, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, Newtown, PA, New York City, and Zug, Switzerland, the firm serves clients throughout North America, Europe, and Japan. Please visit www.campbellalliance.com.

About the Johns Hopkins University Center for Biotechnology Education

The Johns Hopkins University Center for Biotechnology Education was created to engage diverse audiences in the world of biotechnology and to prepare the leaders of today, tomorrow, and the next generation for the challenges of the 21st century. By expanding the scope of biotechnology education, the Center for Biotechnology Education is building a pipeline of students and professionals prepared to achieve success in the development, regulation and commercialization of new biotechnology products. We offer graduate education in the fields of biotechnology, bioinformatics, bioscience regulatory affairs, and biotechnology enterprise and leadership. Please visit our website, http://biotechnology.jhu.edu

Be included in official convention coverage: Tag your convention related content, blog posts, photos and videos with #bio2011
BIO Business Forum: #bio1x1
BIO Exhibitors: #bioex
Follow us on Twitter
Listen to our podcasts
Join us on Facebook
Connect with us on LinkedIn
Participate in our Meet-ups
Visit our YouTube Channel
View our photo albums on Flickr



CONTACT:

Biotechnology Industry Organization (BIO)
Tracy Cooley, APR
202-312-9274
[email protected]

KEYWORDS:   United States  North America  District of Columbia

INDUSTRY KEYWORDS:   Health  Alternative Medicine  Biotechnology  Clinical Trials  Pharmaceutical  Research  Other Science  Science

MEDIA:

Logo
 Logo

Suggested Articles

German viral vector CDMO Vibalogics has hired Lonza veteran Tom Hochuli as global CEO to help lead its U.S. expansion efforts.

Merck’s Keytruda already boasts an OK in some esophageal cancer patients, but it’s looking to widen its reach in the tough-to-treat disease.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.